Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today provided an update on the open-label arm of the non-registrational Phase 2 KeyVibe-002 trial. KeyVibe-002 is…
WHO has updated its tracking system and working definitions for variants of SARS-CoV-2, the virus that causes COVID-19, to better correspond to the current global variant landscape, to independently evaluate…
The antiviral is efficacious in non-human primates, and is safe and well-tolerated in humans Findings support further clinical development for prevention and treatment of dengue, which impacts millions of people…
Commitments demonstrate leadership in advancing health equity and workforce representation to better serve patients and communities – $10 million in 2023 grant funding to 17 U.S. organizations focused on addressing social determinants…
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the U.S. Food and Drug Administration (FDA) granted emergency use authorization (EUA) to provide a single booster dose…
artnership for Healthy Cities award recipients include Montevideo, Uruguay for food policy; Mexico City, Mexico for road safety; Vancouver, Canada for surveillance; Athens, Greece for overdose prevention, and Bengaluru, India…
Pfizer Inc. and Seagen Inc. today announced that they have entered into a definitive merger agreement under which Pfizer will acquire Seagen, a global biotechnology company that discovers, develops and…
The World Health Organization (WHO) released today an updated WHO health workforce support and safeguards list 2023, identifying 55 countries as vulnerable for availability of health workers required to achieve the…
Biogen Inc. today announced the appointment of Chuck Triano as Senior Vice President, Head of Investor Relations effective 10 April 2023. Mr. Triano will report to Michael McDonnell, Executive Vice…
Ready-to-use AgPowered Services from Bayer running on the new Microsoft Azure Data Manager for Agriculture / Readymade capabilities and robust digital infrastructure allow innovators to focus on differentiated value /…
Treatment with fezolinetant resulted in statistically significant reductions in the frequency and severity of VMS and improvements in quality of life Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji…
XTANDI® (enzalutamide) plus androgen deprivation therapy (ADT) significantly delays time to PSA progression compared to placebo plus ADT Study enrolled 180 men with metastatic hormone-sensitive prostate cancer in mainland China Astellas…